Anti-ERBB1/EGFR/HER1 Antibody (Cetuximab)
Catalog No.
F1404
Anti-ERBB1/EGFR/HER1 Antibody (Cetuximab)
Featured Products
Cetuximab (C225) is a human IgG1 monoclonal antibody that can inhibit EGFR. The SPR method measured the Kd value of Cetuximab for EGFR to be 0.201 nM; Cetuximab has a highly effective anti-tumor effect.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- COA (Certificate Of Analysis)
- MSDS (Material Safety Data Sheet)
- Datasheet
145.56 kDa
Dry ice
205923-56-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Erbitux, IMC-C225
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P00533
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Human EGFR CHO-K cells were stained with Anti-ERBB1/EGFR/HER1 Antibody (Cetuximab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS
ERBB1 / EGFR / HER1
Please avoid freeze-thaw cycles.